76 related articles for article (PubMed ID: 12894156)
1. Coaxing coagulation with RNA and cell fragments.
High KA
Nat Med; 2003 Aug; 9(8):991-2. PubMed ID: 12894156
[No Abstract] [Full Text] [Related]
2. Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing.
Chao H; Mansfield SG; Bartel RC; Hiriyanna S; Mitchell LG; Garcia-Blanco MA; Walsh CE
Nat Med; 2003 Aug; 9(8):1015-9. PubMed ID: 12847523
[TBL] [Abstract][Full Text] [Related]
3. Animal testing of retroviral-mediated gene therapy for factor VIII deficiency.
Greengard JS; Jolly DJ
Thromb Haemost; 1999 Aug; 82(2):555-61. PubMed ID: 10605751
[No Abstract] [Full Text] [Related]
4. Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon.
Liu L; Mah C; Fletcher BS
Mol Ther; 2006 May; 13(5):1006-15. PubMed ID: 16464640
[TBL] [Abstract][Full Text] [Related]
5. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A.
Hrachovinová I; Cambien B; Hafezi-Moghadam A; Kappelmayer J; Camphausen RT; Widom A; Xia L; Kazazian HH; Schaub RG; McEver RP; Wagner DD
Nat Med; 2003 Aug; 9(8):1020-5. PubMed ID: 12858167
[TBL] [Abstract][Full Text] [Related]
6. Sustained factor VIII production in hemophiliac mice 1 year after engraftment with induced pluripotent stem cell-derived factor VIII producing endothelial cells.
Alipio Z; Adcock DM; Waner M; O TM; Fink LM; Ward DC; Ma Y
Blood Coagul Fibrinolysis; 2010 Jul; 21(5):502-4. PubMed ID: 20595826
[No Abstract] [Full Text] [Related]
7. Preclinical animal models for hemophilia gene therapy: predictive value and limitations.
Rawle FE; Lillicrap D
Semin Thromb Hemost; 2004 Apr; 30(2):205-13. PubMed ID: 15118932
[TBL] [Abstract][Full Text] [Related]
8. Expression of human coagulation factor VIII in adipocytes transduced with the simian immunodeficiency virus agmTYO1-based vector for hemophilia A gene therapy.
Ogata K; Mimuro J; Kikuchi J; Tabata T; Ueda Y; Naito M; Madoiwa S; Takano K; Hasegawa M; Ozawa K; Sakata Y
Gene Ther; 2004 Feb; 11(3):253-9. PubMed ID: 14737084
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of factor VIII in hemophilia.
Eckhardt CL; Kamphuisen PW; Fijnvandraat K
N Engl J Med; 2009 Jul; 361(3):309; author reply 310. PubMed ID: 19610163
[No Abstract] [Full Text] [Related]
10. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
[TBL] [Abstract][Full Text] [Related]
11. The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy.
Youjin S; Jun Y
Biotechnol Lett; 2009 Mar; 31(3):321-8. PubMed ID: 18979215
[TBL] [Abstract][Full Text] [Related]
12. Novel human pathological mutations. Gene symbol: F8. Disease: haemophilia A.
Garcia-Lozano JR
Hum Genet; 2007 Nov; 122(3-4):420. PubMed ID: 18350668
[No Abstract] [Full Text] [Related]
13. Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A.
Delignat S; Dasgupta S; André S; Navarrete AM; Kaveri SV; Bayry J; André MH; Chtourou S; Tellier Z; Lacroix-Desmazes S
Haematologica; 2007 Oct; 92(10):1423-6. PubMed ID: 18024377
[TBL] [Abstract][Full Text] [Related]
14. An update on gene therapy for hemophilia.
Nathwani AC; McIntosh J; Davidoff AM
Curr Hematol Rep; 2005 Jul; 4(4):287-93. PubMed ID: 16009043
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for hemophilia.
Ponder KP
Curr Opin Hematol; 2006 Sep; 13(5):301-7. PubMed ID: 16888433
[TBL] [Abstract][Full Text] [Related]
16. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
[TBL] [Abstract][Full Text] [Related]
17. A promising treatment for hemophilia.
Dorans K
Lab Anim (NY); 2011 Jul; 40(8):233. PubMed ID: 21772340
[No Abstract] [Full Text] [Related]
18. Future aspects of hemophilia research and care.
Valentino LA; Scheiflinger F
Semin Thromb Hemost; 2006 Jun; 32 Suppl 2():32-8. PubMed ID: 16804834
[TBL] [Abstract][Full Text] [Related]
19. Retroviral modification of mesenchymal stem cells for gene therapy of hemophilia.
Doering CB
Methods Mol Biol; 2008; 433():203-12. PubMed ID: 18679625
[TBL] [Abstract][Full Text] [Related]
20. AAV-mediated gene therapy for hemophilia.
Couto LB; Pierce GF
Curr Opin Mol Ther; 2003 Oct; 5(5):517-23. PubMed ID: 14601521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
